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Recent studies have provided an unprecedented view of the trillions of microbes
associated with the human body. The human microbiome harbors tremendous
diversity at multiple levels: the species that colonize each individual and each
body habitat; the genes that are found in each organism’s genome; the
expression of these genes and the interactions and activities of their protein
products. The sources of this diversity are wide-ranging and reﬂect both
environmental and host factors. A major challenge moving forward is deﬁning
the precise functions of members of various families of proteins represented
in our microbiomes, including the highly diverse carbohydrate-active enzymes
(CAZymes) involved in numerous biologically important chemical transforma-
tions, such as the degradation of complex dietary polysaccharides. Coupling
metagenomic analyses to structural genomics initiatives and to biochemical and
other functional assays of CAZymes will be essential for determining how these
as well as other microbiome-encoded proteins operate to shape the properties of
microbial communities and their human hosts.
The human body is home to trillions of microorganisms, most of
whom reside in our gastrointestinal tracts. A century ago, Arthur
Kendall wrote
the multiplicity of types and variety of physiological requirements of this
intestinal ﬂora are ... a strong reminder of the inﬂuence which the
unrestrained activity ofthese organisms might conceivably exercise upon
the general condition of the host
(Kendall, 1909). Fast-forward 100 years and culture-independent
metagenomic studies are now generating a tsunami of DNA-
sequence data characterizing the genetic components of our
microbiomes. For example, recent reports have described the results
of (i) surveying the microbial composition of 27 different
body-habitat-associated communities within and between multiple
individuals over time (Costello et al., 2009); (ii) deeply sequencing the
human gut microbiomes of genetically identical and unrelated indi-
viduals (Qin et al., 2010; Turnbaugh et al., 2010); (iii) analyzing ethnic
variations in vaginal microbiomes (Ravel et al., 2010) and (iv)
producing reference databases composed of hundreds (and soon to
be thousands) of genome sequences from cultured representatives of
various human microbiota (Nelson et al., 2010).
While these human microbiome projects (HMPs) are rapidly
expanding the number of gene sequences being deposited in public
databases, as is the case with the human genome project there are
signiﬁcant challenges in developing efﬁcient and economical strate-
gies for exploiting these data in order to gain insights into the func-
tions of protein products and how they contribute to human
physiology, physiological variations, disease risk and disease patho-
genesis. Addressing these challenges requires an integration of many
experimental approaches, ranging from functional metagenomics
(Craig et al., 2010; Uchiyama & Miyazaki, 2009; Sommer et al., 2009,
2010) to high-throughput genetic screens to identify determinants of
symbiont ﬁtness in a given microbial community or host context
(Goodman et al., 2009) and structural genomics initiatives targeted to
various groups of microbiome-speciﬁed proteins (see papers in this
issue).One issue that potentially confounds the design of microbiome-
directed structural genomic ‘campaigns’ is the incredible amount of
microbial organismal and genetic diversity found in communities
occupying various human-body habitats. A recent deep sampling,
using culture-independent metagenomic methods, of the fecal
microbiota of an adult monozygotic female twin pair revealed an
estimated 800–900 bacterial species in each co-twin, less than half
of which were shared by both individuals (Turnbaugh et al., 2010).
Expanding this analysis to include a shallower sampling of 281 fecal
samples obtained from 54 monozygotic and dizygotic twin pairs and
their mothers revealed >4000 gut-associated species-level phylo-
genetic types (phylotypes). However, of the 134 bacterial species
whose relative abundance was >0.1% in at least one fecal community,
only 37 were detected in more than half of the biospecimens collected
in this survey of 150 individuals.
Deep shotgun pyrosequencing of fecal community DNAs prepared
from the monozygotic twin pair referred to above yielded >100 000
protein-coding gene clusters. Only 17% of the clusters identiﬁed in
this combined 10.1 Gbp data set were shared between these
‘genetically identical’ individuals; 49% encoded hypothetical proteins
(no assignable COG, GO-term, TIGRfam or Pfam annotations) and
only 36% had signiﬁcant matches to known or predicted proteins
present in the genomes of 122 cultured members of the human gut
microbiota (Turnbaugh et al., 2010).
Annotation of the genes identiﬁed in this deeply sampled gut-
microbiome data set using the carbohydrate-active enzymes (CAZy)
database (Cantarel et al., 2009) disclosed 143 different CAZy families
encoded by 5145 genes (Turnbaugh et al., 2010). The revealed
CAZyme repertoire emphasizes two themes emerging from present-
day explorations of the human gut microbiome: substantial inter-
personal variation and the disclosure of unanticipated functions. For
example, genomic segments from the genus Faecalibacterium in the
microbiome of one co-twin contained a number of genes encoding
predicted cellulases [members of glycoside hydrolase family 5 (GH5),
GH9, GH44 and GH48] plus 42 genes encoding putative dockerins
(small proteins that aid in the assembly of extracellular cellulosomes;
Bayer et al., 2008). These genes were notably absent in her co-twin’s
microbiome or in a draft genome assembly produced from
F. prausnitzii strain M21/2. Pyrosequencing reads homologous to
predicted dockerins were found in 18 other human fecal micro-
biomes, representing six sets of adult monozygotic twins and their
mothers, but varied in their abundance between individuals within
and between families (Turnbaugh et al., 2010).
Tallying the results of the metagenomic analysis of these gut-
microbiome data sets from families containing monozygotic twins has
so far yielded 156 CAZy families (including 77 glycoside hydrolase,
21 carbohydrate-binding module, 35 glycosyltransferase, 12 poly-
saccharide lyase and 11 carbohydrate esterase families). This means
that CAZymes represent on average 2.6% of the sequenced genes in
each microbiome (Turnbaugh et al., 2009). In contrast, the human
genome encodes at best 20–25 digestive enzymes from CAZy families
GH1 (lactase), GH13 (-amylase) and GH31 (maltase, isomaltase
and sucrase). Thus, with the exception of starch and sucrose, our
ability to digest dietary plant carbohydrates resides entirely in our gut
microbiomes.
The CAZymes represented in different human populations
consuming different diets may be inﬂuenced by their varied cultural
traditions. This point is illustrated by a recent study that started out
by investigating the polysaccharide-degrading capabilities of Zobellia
galactanivorans, a marine Bacteroidete that can metabolize
porphyran derived from marine red algae belonging to the genus
Porphyra (Hehemann et al., 2010). Porphyranases from
Z. galactanivorans were isolated, their biochemical activities were
conﬁrmed and the structures of two of them were determined by
X-ray crystallography (PDB entries 3juu and 3ilf; Hehemann et al.,
2010). Homologous genes were found in the common human gut
bacterium Bacteroides plebeius. Intriguingly, these genes were
represented in the gut microbiomes of Japanese but not North
American individuals. These ﬁndings are consistent with a horizontal
gene-transfer event whereby porphyranases from an ancestral marine
bacterium related to the Bacteroidetes Z. galactanivorans and
Microscilla sp. PRE1 were acquired by a resident member of the gut
microbiota of Japanese consumers of nonsterile food; this micro-
biome-acquired trait may have then been disseminated to other
members of this human society.
Systematic application of high-throughput structural genomics
initiatives to CAZymes represented in human microbiomes will
undoubtedly yield protein folds together with the expectation that
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Table 1
Proportion of functionally and structurally characterized glycoside hydrolases
(GHs), polysaccharide lyases (PLs) and glycosyltransferases (GTs) in the CAZy
database as of June 2010.
GHs PLs GTs
Entries with assigned enzyme-classiﬁcation numbers (%) 6.7 11.0 2.9
Entries whose structures have been determined (%) 0.75 2.4 0.17
Figure 1
CAZymes are modular and increasingly described only by high-throughput sequencing data. (a) Growth of sequence, functional and structural data in the CAZy database.
(b) Example of modular variation in CAZymes containing a common CBM10 domain.new insights/predictions about their functions will ensue. However,
proteins that interact with complex carbohydrates pose some difﬁcult
challenges when trying to elucidate function ‘just’ through fold
determination. The reason relates at least in part to the fact that these
proteins must selectively recognize and process one of the most
diverse classes of biological substrates on Earth: substrates that
possess an enormous range of stereochemical and structural varia-
tions (Laine, 1994). These variations in turn are harnessed by living
organisms to fulﬁll very different roles: e.g. structural, storage,
speciﬁc signaling, speciﬁc recognition among myriad similar mole-
cules, host–pathogen interactions and exchanges between symbionts
to name but a few. Predictions such as ‘putative glycoside hydrolase’
or ‘putative carbohydrate-binding protein’ are still a long way from
what is desirable, owing to the different functions that carbohydrates
achieve depending on seemingly small structural variations. A vivid
example is provided by polymers of d-glucose residues linked
between C atoms 1 and 4: if the glycosidic bond is  the polymer is
amylose and is used for carbon storage by most cells; if the glycosidic
bond is  the polymer is cellulose, one of nature’s toughest structural
polysaccharides.
Carbohydrate diversity greatly exceeds the number of known
protein folds and is undoubtedly one reason for the observed diver-
sity of genes encoding putative CAZymes (Fig. 1a). One consequence
is that gene families group together enzymes with widely different
substrate or product speciﬁcities (Henrissat, 1991). Another conse-
quence is that to derive knowledge useful for subsequent functional
predictions, we must adopt a divide-and-conquer approach whereby
subgroups (subfamilies, clusters) are deﬁned within families and then
functional characterization in each subgroup without a biochemically
established member is performed. This process needs reﬁnement, as
the appropriate threshold for deﬁning a subfamily is likely to vary
from one family to another. For example, there are extreme cases
such as blood-group transferases where two amino-acid changes
switch the substrate speciﬁcity for the transferred carbohydrate from
galactose to N-acetylgalactosamine, thereby changing the resulting
blood-group epitope from B to A (Seto et al., 1999). At the other end
of the spectrum, cellulases with as little as 10% sequence identity can
digest the same substrate (Henrissat et al., 1989).
Microbes are particularly ingenious at inventing novel CAZymes,
either from other CAZymes or from other ‘pre-existing’scaffolds; e.g.
at least ﬁve different folds are known for cellulases (1cec, 1cb2, 1cel,
1clc, 2eng; Dominguez et al., 1995; Koivula et al., 1996; Divne et al.,
1994; M. B. Lascombe, H. Souchon, M. Juy & P. M. Alzari, unpub-
lished work; Davies et al., 1995). CAZymes have a highly variable
modular structure, with the catalytic module carrying a variable
number of ancillary modules. Each module can provide a comple-
mentary catalytic activity or carbohydrate-binding, protein-binding,
cell-binding (or other unknown) capabilities. The number of domain
combinations is very large and this is one way devised by living
organisms to increase the number of carbohydrate-interacting
proteins using a limited number of folds. A consequence of this
modular variability (Fig. 1b) is that the precise function of a module
sitting next to a carbohydrate-binding module (CBM) is hard to
predict since it could be catalytic (e.g. glycoside hydrolase, poly-
saccharide lyase, carbohydrate esterase, protease or kinase) or
noncatalytic (e.g. another CBM, a membrane-attachment domain or a
module involved in cell adhesion or in cellulosome assembly). Some
carbohydrate-interacting proteins are made of a single CBM, while
others may contain two noncatalytic modules (e.g. CBM33-CBM2;
expansins). Syntrophy (cross-feeding) between any two organisms
can be conceptualized as the proportion of ‘seeds’ (molecules
acquired exogenously from the environment; Borenstein et al., 2008)
that are intermediates or end products in another, while competition
can be viewed as the number of seeds that are shared. Microbes need
to remain in the vicinity of their seeds (substrates) to establish and
maintain syntrophic relationships and it is entirely possible that some
dual binding proteins exist to bind a carbohydrate on the one hand
and some component of a neighbor’s cell surface on the other.
One class of CAZymes, the glycosyltransferases (GT), are parti-
cularly difﬁcult to study experimentally owing to their frequent
association with membranes, their poor stability in pure form and
their low solubility (Davies et al., 2005). Assays for enzymatic func-
tion are also difﬁcult because the nucleotide diphospho-sugar donor
must be identiﬁed along with the acceptor, which could potentially
span a wide range of molecules. In addition, GTs may lack great
speciﬁcity in vitro. This observation can be rationalized by the fact
that GTs frequently encounter a narrow set of donor/acceptor
molecules by virtue of their compartmentalization within cells or
because metabolic ﬂuxes deliver the ‘appropriate’ reagents to these
enzymes. Moreover, the few structural studies of GTs reported to
date have revealed that they undergo important conformational
changes upon ligand binding and that only the ternary complex with
both donor and acceptor achieves the conformation suitable for
catalysis (Lairson et al., 2008). While signiﬁcant success has been
achieved by structural genomics initiatives with proteins that bind or
break down complex carbohydrates, the number of GT structures
remains comparatively modest (Table 1).
Even if a structure is solved for a putative glycoside hydrolase, it
can bedifﬁcult toinfer itsfunction. Oneway aroundthis problem isto
determine whether there are conserved aspartate or glutamate resi-
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Table 2
Examples of ‘misleading’ CAZymes or CAZyme-like proteins.
Protein Description Reference
Myrosinase A plant sugar-cleaving enzyme that has evolved from GH1
-glucosidases by losing one of the two catalytic Glu residues, which
has been replaced by an ascorbate cofactor.
Burmeister et al. (2000)
-Lactalbumin Noncatalytic protein; shares 40% sequence identity with type C
lysozymes; would be predicted to be a lysozyme based on sequence
similarity.
Brew et al. (1967)
Wheat xylanase inhibitor protein XIP-I A xylanase inhibitor that displays sequence and structural similarity to
chitinases, but has nonetheless lost its catalytic activity. Many
orthologs are still annotated in GenBank as putative chitinases (for
example, GenBank BAC10141).
Payan et al. (2004)
Glycosidase family 97 proteins (GH97) This family contains two subgroups, each with different catalytic
machinery and stereochemical outcome, making it difﬁcult to deﬁne
the catalytic machinery based on invariant acidic residues.
Gloster et al. (2008)
Glycosidase GH4 and GH109 proteins Proteins from these families would be classiﬁed as NAD oxido-
reductases based on sequence and structure only.
Liu et al. (2007)dues that are suitably positioned to perform catalysis (McCarter &
Withers, 1994; Davies & Henrissat, 1995, 2002). Although the cata-
lytic residues of GHs are usually strictly conserved, there are exam-
ples that serve as a warning against over-interpretation of in silico
predictions and as a strong incentive for rigorous experimental
characterization (Table 2). Currently, there are several active colla-
borative efforts for research and education in the glycosciences both
in the USA and Europe; e.g. the Consortium for Functional Glyco-
mics (http://www.functionalglycomics.org/), the Euroglycosciences
Forum (http://www.egsf.org/) and the German Glycosciences Initia-
tive (http://www.glycosciences.de/). These resources could be
expanded and/or used as starting points for additional efforts aimed
at systematic functional characterization of carbohydrate-active
enzymes identiﬁed by mining the massive data sets emanating from
the ever-increasing numbers of metagenomic studies of microbial
communities.
In summary, for CAZymes, CBMs and other sugar-interacting
proteins, perhaps more than for any other protein class, there is an
enormous need to join metagenomics together with structural biology
initiatives and to link the output with functional assays. In this
respect, the remarkable structures of microbiome-encoded proteins
that are being solved through structural genomics initiatives repre-
sent islands in a sea of insecure predictions. Follow-up biochemical
work needs to be performed to identify the actual carbohydrate
structures recognized and processed by a given protein whose fold
has been characterized. Accelerating the pace of discovery of these
carbohydrate structures will require new experimental innovations,
as well as the sponsorship of individuals who wish to train in the
glycosciences.
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